October 19th is Max’s Day. We honor the day because it marks Max’s birthday. At the very same time, we honor all the people who have been helped in his name.
Max’s name has become a symbol of hope around the world through the work of The Max Foundation. And beneath it, lifting it higher and higher for all to see, are more than 70 team members and countless advocates across different sectors all working together to expand treatment access for people facing cancer. You all choose to wake up every day and honor Max’s name and build his legacy. For that, I am forever grateful.
At The Max Foundation, we often say, “Access to treatment is access to life.” They are words we live by and make manifest through our extensive network of partner healthcare providers and a Humanitarian PACT among our corporate partners: key pieces of a treatment access model that delivers medicine to people who need it, just like Max needed.
Throughout October, we are asking ourselves and our friends around the world to consider what access to treatment means for each of us. So, as we embrace Max’s Day with honor and reflection, I ask you to reflect on a simple question: what does treatment access mean to you?
Pat Garcia-Gonzalez is the CEO of The Max Foundation. Under Pat’s direction The Max Foundation is dedicated to accelerating health equity by delivering medication, technology, and services to patients facing cancer and other critical illnesses, focusing our energy on those who no one else is helping. Pat lives in Edmonds, Washington, where she raised her four sons.
When Ka came to Thailand for access to treatment, she had the chance to join the MaxSmiles patient group meetings. Ka started to dream about having her own meetings and soon found support from Dr. Mary Cluck, an Australian volunteer working with Cambodian CML patients. Ka stepped up and called the patients one-by-one to invite them to their first patient meeting.
Radha Bai Chandra is a 62-year-old widow, a mother, and the longest-surviving beneficiary of Max’s programs in Fiji. Although her search for treatment was long and challenging, the second life she now has from that search is worth it. In 2005, Radha Bai noted a change in her energy levels. She was usually an active….
For people living with chronic myeloid leukemia (CML), regular disease monitoring using polymerase chain reaction (PCR) testing is critical to achieving successful health outcomes. Mutation testing is another key test for individuals who fail to respond to one or more treatments. Despite the importance of these tests, they are unaffordable and therefore inaccessible for many people living with CML in the Philippines.
